BROWSE

Related Researcher

Author's Photo

Ryu, Ja-Hyoung
Supramolecular NanoMaterials Lab (SUN)
Research Interests
  • Supramolecular assembly, synthetic peptide assembly, cancer drug delivery

ITEM VIEW & DOWNLOAD

Cancer-targeted nanomedicine: overcoming the barrier of protein corona

DC Field Value Language
dc.contributor.author Barui, Ayan Kumar ko
dc.contributor.author Oh, Jun Yong ko
dc.contributor.author Jana, Batakrishna ko
dc.contributor.author Kim, Chaekyu ko
dc.contributor.author Ryu, Ja-Hyoung ko
dc.date.available 2019-10-04T00:44:29Z -
dc.date.created 2019-09-29 ko
dc.date.issued 2020-01 ko
dc.identifier.citation ADVANCED THERAPEUTICS, v.3, no.1, pp.1900124 ko
dc.identifier.issn 2366-3987 ko
dc.identifier.uri https://scholarworks.unist.ac.kr/handle/201301/27783 -
dc.description.abstract Nanomedicines exploit the unusual physicochemical and biological properties of nanoparticles, including their nanoscopic size, high surface‐area‐to‐volume ratio, easy surface modification, and biocompatibility. Among various therapeutic and diagnostic applications of nanomedicines, cancer‐targeted drug delivery systems (DDS) have been found to be a promising area of research. Effective DDS rely on two major factors: slow and sustained release of chemotherapeutic drugs and their targeted delivery to tumor sites. Both the drug release and targeting ability of nanoparticles are greatly affected under in vivo conditions by the “protein corona,” a tightly packed layer of protein molecules, formed around nanoparticles upon contact with biological fluids. Owing to the adsorption of proteins onto the surface of nanoparticles, their identity is significantly altered, and they can readily be cleared from systemic circulation by the mononuclear phagocytic system. In this context, scientists have employed various strategies, including the use of different ligands, stealth polymers, and protein corona shields/pre‐coating with specific proteins to modulate protein corona formation and retain the targeting ability of nanoparticles. This review article focuses on the recent progress of these different strategies with a special emphasis on the protein corona shields/artificial protein corona approaches for the development of effective cancer targeting nanomedicines. ko
dc.language 영어 ko
dc.publisher Wiley Blackwell ko
dc.title Cancer-targeted nanomedicine: overcoming the barrier of protein corona ko
dc.type ARTICLE ko
dc.identifier.wosid 000506403400010 ko
dc.type.rims ART ko
dc.identifier.doi 10.1002/adtp.201900124 ko
dc.identifier.url https://onlinelibrary.wiley.com/doi/full/10.1002/adtp.201900124 ko
Appears in Collections:
CHM_Journal Papers

find_unist can give you direct access to the published full text of this article. (UNISTARs only)

Show simple item record

qrcode

  • mendeley

    citeulike

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

MENU